Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  Label: Drug-induced localized lipodystrophy
  ORPHAcode: '90157'
  ORPHApacketId: '90157'
  PURL: http://www.orpha.net/ORDO/Orphanet_90157
  Parents:
  - Parent:
    - Label: Localized lipodystrophy
      ORPHAcode: '79088'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0100578
      HPOTerm: Lipoatrophy
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003758
      HPOTerm: Reduced subcutaneous adipose tissue
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007485
      HPOTerm: Absence of subcutaneous fat
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000953
      HPOTerm: Hyperpigmentation of the skin
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001010
      HPOTerm: Hypopigmentation of the skin
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010783
      HPOTerm: Erythema
  Synonyms:
  - Synonym: Lipoatrophy caused by injected drug
  TextSection:
    Contents: Drug-induced localized lipodystrophy is a rare acquired localized lipodystrophy
      characterized by the appearance of asymptomatic well-demarcated variably sized
      depressed lipoatrophic lesions secondary to subcutaneous intradermic or intramuscular
      drug injection including corticosteroids insulin human growth hormone and antibiotics.
      Skin coloration may vary from white or hypopigmented to reddish pinkish or violaceous.
      Epidermal atrophy may be also present.
    TextSectionType: Definition
  copyright: Orphanet (c) 2023
  creationDate: '2023-12-06 11:51:54'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
